Recent Articles from GlobeNewswire
By UP Fintech Holding Limited · Via GlobeNewswire · December 4, 2025
UTRECHT, the Netherlands - 4 December 2025 (08:30 CET). Laigo Bio, a company pioneering novel and highly differentiated therapies using its proprietary SureTAC™ precision membrane protein degradation platform, has successfully raised €11.5 million in a seed financing. The company will use the proceeds to advance its SureTAC™ oncology programs towards clinical development, and to accelerate discovery and development of its three SureTAC™ immunology candidate therapeutic programs for selected autoimmune and immunology indications and graft rejection.
By Laigo Bio · Via GlobeNewswire · December 4, 2025
CABs ENDORSE NORRA KÄRR MINING LEASE APPLICATION
By Leading Edge Materials Corp. · Via GlobeNewswire · December 4, 2025
By Heineken · Via GlobeNewswire · December 4, 2025
Ad Hoc Announcement Pursuant to Art. 53 LR
By Addex Therapeutics · Via GlobeNewswire · December 4, 2025
Nokia partners with Bharti Airtel to unlock 5G capabilities for developers and enterprises via network APIs
By Nokia Oyj · Via GlobeNewswire · December 4, 2025
Speaking at India Blockchain Week, Elkaleh argued that simplicity and security aren't enough — mass adoption will come when Web3 wallets become genuinely useful in everyday life
By Bitget Limited · Via GlobeNewswire · December 3, 2025
LOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) -- URBANICA Furniture today announced the launch of its new Wellness First Chair Collection, a research-backed line of ergonomic seating created to address fatigue, discomfort, and performance loss that many home office workers experience during long workdays. The collection is designed for modern professionals who want healthier work routines, improved posture, and better long-term comfort.
By URBANICA · Via GlobeNewswire · December 3, 2025
Grand Cayman, Cayman Islands, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Crown Reserve Acquisition Corp. I (the “Company”) announced today that, commencing on or about Tuesday, December 9, 2025, holders of the units sold in the Company’s initial public offering may elect to separately trade the Class A ordinary shares, warrants, and rights included in the units.
By CROWN RESERVE ACQUISITION CORP. I · Via GlobeNewswire · December 3, 2025
By Faraday Future · Via GlobeNewswire · December 3, 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · December 3, 2025
By The Hemp Doctor · Via GlobeNewswire · December 3, 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · December 3, 2025
By Bombardier Inc. · Via GlobeNewswire · December 3, 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · December 3, 2025
By Benfen Inc. · Via GlobeNewswire · December 3, 2025
Seasoned technologist, investor, and capital markets leader joins Hapbee’s Board
By Hapbee Technologies, Inc. · Via GlobeNewswire · December 3, 2025
New York, New York, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Columbus Circle Capital Corp I ("BRR") (Nasdaq: BRR) and ProCap BTC, LLC ("ProCap BTC"), a modern financial services firm leveraging bitcoin, today announced that BRR’s shareholders voted to approve the proposed business combination with ProCap BTC ("Business Combination") at an extraordinary general meeting held today.
By Columbus Circle Capital Corp. I · Via GlobeNewswire · December 3, 2025
ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of peripheral nerve function, today announced that the U.S. Food and Drug Administration (the “FDA”) has approved the Biologics License Application (“BLA”) for AVANCE® (acellular nerve allograft-arwx).
By Axogen, Inc. · Via GlobeNewswire · December 3, 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Stride, Inc. (“Stride” or the “Company”) (NYSE:LRN) investors of the January 12, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action.
By Kirby McInerney LLP · Via GlobeNewswire · December 3, 2025
Herzliya, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Regentis Biomaterials Ltd. (NYSE American: RGNT) (“Regentis”, or the “Company”), a regenerative medicine company dedicated to developing innovative tissue repair solutions that seek to restore the health and enhance the quality of life of patients, today announced the pricing of its initial public offering (the “Offering”) of 1,250,000 ordinary shares (“Ordinary Shares”) at an initial public offering price of $8.00 per Ordinary Share, for aggregate gross proceeds of $10,000,000 before deducting underwriting discounts and estimated offering expenses payable by the Company. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 187,500 Ordinary Shares to cover over-allotments, if any.
By Regentis Biomaterials Ltd. · Via GlobeNewswire · December 3, 2025
SINGAPORE, Dec. 03, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Jason Leow as a Senior Managing Director within the firm’s Strategic Communications segment.
By FTI Consulting, Inc. · Via GlobeNewswire · December 3, 2025
GRAND CAYMAN, Cayman Islands, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Activate Energy Acquisition Corp. (Nasdaq: AEAQU) (the “Company”) announced today the pricing of its initial public offering of 20,000,000 units at $10.00 per unit. The units will be listed on The Nasdaq Global Market tier of The Nasdaq Stock Market LLC (“Nasdaq”) and begin trading on December 4, 2025, under the ticker symbol “AEAQU.” Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “AEAQ” and “AEAQW,” respectively. The offering is expected to close on December 5, 2025, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,000,000 units at the initial public offering price to cover over-allotments, if any.
By Activate Energy Sponsors LLC · Via GlobeNewswire · December 3, 2025
The new solution centralizes ChatGPT, Claude, Gemini, Grok, and Perplexity to reduce workload and accelerate digital output for small businesses.
By Aided · Via GlobeNewswire · December 3, 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · December 3, 2025
THE WOODLANDS, Texas, Dec. 03, 2025 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 398 homes in November 2025, which includes the closing of 8 currently or previously leased single-family rental homes.
By LGI Homes, Inc. · Via GlobeNewswire · December 3, 2025
NORTH WALES, Pa., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Toppoint Holdings Inc. (the “Company”) announced today that A.G.P./Alliance Global Partners, the representative of the underwriters in the Company’s recent public sale of shares of its common stock, are waiving a lock-up restriction with respect to 7,500,000 shares of its common stock held by an officer of the Company. The waiver will take effect immediately, and the shares of its common stock may be sold on or after such date.
By Toppoint Holdings Inc · Via GlobeNewswire · December 3, 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Firefly Aerospace Inc. (“Firefly” or the “Company”) (NASDAQ:FLY) investors of the January 12, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action.
By Kirby McInerney LLP · Via GlobeNewswire · December 3, 2025
Executive Chef–turned–Franchisee Brandon Thordarson leverages culinary and brand expertise to lead the Nation’s Capital debut
By Moxies · Via GlobeNewswire · December 3, 2025
LAS VEGAS, NV, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Safeguard Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units will be listed on the New York Stock Exchange (the “NYSE”) and are expected to trade under the ticker symbol “SAC.U” beginning on December 4, 2025. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Only whole warrants will be exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the warrants are expected to be listed on the NYSE under the symbols “SAC” and “SAC WS,” respectively. Only whole warrants will trade. The offering is expected to close on December 5, 2025. Safeguard Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination in any industry, sector or geographic region, it expects to target opportunities and companies in the aerospace & defense, government services & national security, and space sectors. Jefferies is acting as the sole book-running manager for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,000,000 units at the initial public offering price to cover over-allotments, if any. A registration statement relating to these securities has become effective pursuant to Section 8(a) of the Securities Act of 1933, as amended. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering is being made only by means of a prospectus. Copies of the prospectus may be obtained, when available, from Jefferies LLC, 520 Madison Avenue, New York, NY 10022, Attention: Equity Syndicate Prospectus Department, or by telephone at 877-821-7388 or email at Prospectus_Department@Jefferies.com.
By Safeguard Acquisition Corp. · Via GlobeNewswire · December 3, 2025
Company recognized by Newsweek for its commitment to corporate responsibility and sustainability
By Winnebago Industries, Inc. · Via GlobeNewswire · December 3, 2025
LAKEWOOD, Colo., Dec. 03, 2025 (GLOBE NEWSWIRE) -- - Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern Time (ET) on Tuesday, February 3, 2026.
By Mesa Laboratories, Inc. · Via GlobeNewswire · December 3, 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of DeFi Technologies Inc. (NASDAQ: DEFT), Skye Bioscience, Inc. (NASDAQ:SKYE) and Perrigo Company plc (NYSE:PRGO). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · December 3, 2025
WALTHAM, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that The New England Journal of Medicine (NEJM) published positive results from the Phase 3 VALIANT study investigating EMPAVELI® (pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN), which are severe and rare kidney diseases.
By Apellis Pharmaceuticals, Inc. · Via GlobeNewswire · December 3, 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · December 3, 2025
MONTREAL, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier”) today announced that it has redeemed all remaining outstanding US$99,431,000 aggregate principal amount of its 7.875% Senior Notes due 2027 (the “Redemption Notes”), as set forth in the notice of redemption issued November 3, 2025. This debt redemption was funded using cash from Bombardier’s balance sheet.
By Bombardier Inc. · Via GlobeNewswire · December 3, 2025
RIDGELAND, Miss., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ: CALM), the largest egg company in the United States and a leading player in the egg-based food industry, is strengthening its prepared foods platform through new leadership appointments and targeted prepared foods production capacity expansions.
By Cal-Maine Foods, Inc. · Via GlobeNewswire · December 3, 2025
Record Revenues and Income from Operations; Application Filed to Commence Normal Course Issuer Bid; CFO Transition Plan Outlined for Next Fiscal Year
By The Descartes Systems Group Inc · Via GlobeNewswire · December 3, 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Board of Directors (the “Board”) of Strata Critical Medical, Inc. (“Strata” or the “Company”), a leading provider of logistics and medical services in the organ transplant industry, today announced the appointment of Will Cook to the Board, effective December 3, 2025. Mr. Cook has also been appointed to the Compensation and Nominating and Corporate Governance Committees.
By Strata Critical Medical, Inc · Via GlobeNewswire · December 3, 2025
MONTREAL, Dec. 03, 2025 (GLOBE NEWSWIRE) -- D-BOX Technologies Inc. (TSX: DBO), a global leader in haptic and immersive entertainment technology with systems deployed on well over 1,000 theatrical screens worldwide and a growing leadership position across simulation racing, training, and experiential markets, announces the appointment of Scott Sherr as Chief Commercial Officer, reporting directly to the President and Chief Executive Officer and joining the executive leadership team effective immediately. This appointment reflects D-BOX’s continued focus on strengthening its leadership as it expands its presence across key markets.
By D-BOX Technologies Inc. · Via GlobeNewswire · December 3, 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE:AGL), Soleno Therapeutics, Inc. (NASDAQ:SLNO), AVITA Medical, Inc. (NASDAQ:RCEL), and Coty, Inc. (NYSE:COTY). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · December 3, 2025
COLUMBUS, Ohio, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ: ROOT), a leading technology company powering insurance solutions and the parent company of Root Insurance, today announced its participation in Citi’s 2025 Insurance Access Day, taking place December 8, 2025 in New York, New York.
By Root, Inc. · Via GlobeNewswire · December 3, 2025
CANTON, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG), the leading integrated commerce retailer of Big + Tall men’s clothing and footwear, announced today that, due to a scheduling conflict, it has rescheduled the release of its third quarter 2025 financial results and corresponding conference call, which had been previously scheduled for December 4, 2025. The Company now plans to issue financial results and hold its earnings conference call on December 11, 2025 at 8:30 a.m. ET.
By Destination XL Group, Inc. · Via GlobeNewswire · December 3, 2025
WALTHAM, Mass. and DUBLIN, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc, (Nasdaq: MURA) (“Mural”) announces that the High Court of Ireland has today sanctioned the scheme of arrangement between Mural and its shareholders under Chapter 1 of Part 9 of the Companies Act 2014 (the “Scheme”) pursuant to which XRA 5 Corp. (“Sub”), a wholly-owned subsidiary of XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA Royalty”), will acquire the entire issued and to be issued share capital of Mural (the “Acquisition”).
By Mural Oncology plc · Via GlobeNewswire · December 3, 2025
Seasoned real estate technology leader to oversee integration of Prevu and drive reAlpha’s national brokerage expansion
By reAlpha Tech Corp. · Via GlobeNewswire · December 3, 2025
38.1 million Americans united to give back and donated $4.0 billion, bringing total GivingTuesday donations since 2012 to $22.5 billion
By GivingTuesday · Via GlobeNewswire · December 3, 2025
HOUSTON, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc. (Nasdaq: SKWD) (“Skyward Specialty” or the “Company”) today announced that it has secured the required regulatory approvals and approvals of the minority shareholders of its acquisition of Apollo Group Holdings Limited (“Apollo”). The transaction is expected to close early in the first quarter of 2026, subject to final closing conditions.
By Skyward Specialty Insurance Group, Inc. · Via GlobeNewswire · December 3, 2025
St. Petersburg, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- On December 3, 2025, the Raymond James Financial, Inc. (NYSE: RJF) Board of Directors declared a quarterly cash dividend on shares of its common stock of $0.54 per share, payable January 16, 2026 to shareholders of record on January 2, 2026. This is an 8% increase over the previous dividend of $0.50 per share paid on October 15, 2025.
By Raymond James Financial · Via GlobeNewswire · December 3, 2025
WILMINGTON, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, today announced that it has commenced an underwritten public offering (the “Offering”) of 10,000,000 shares of its Class A common stock by the Company and SVF Sponsor III (DE) LLC, an affiliate of SoftBank Group Corp. (the “Selling Securityholder”). The Company is offering 6,500,000 shares of its Class A common stock and the Selling Securityholder is offering 3,500,000 shares of Class A common stock. Symbotic expects to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of its Class A common stock at the public offering price, less underwriting discounts and commissions.
By Symbotic Inc. · Via GlobeNewswire · December 3, 2025
The Licensing International 2025 Hall of Fame Induction and Global Rising Star Awards Event Honored Industry Greats and Ushered in the Next Generation of Leaders
By Licensing International · Via GlobeNewswire · December 3, 2025
WHEATON, Ill., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Innovator Capital Management, LLC (Innovator), the pioneer of Defined Outcome ETFs™ and a leader in risk-managed equity solutions, today announced the first monthly distribution cycle for its two newest income ETFs: the Innovator Index Autocallable Income Strategy ETF (NYSE Arca: ACII) and the Innovator Equity Autocallable Income Strategy ETF (NYSE Arca: ACEI). The distribution validates the funds’ innovative approach to providing consistent, equity-linked income to meet growing investor demand.
By Innovator Capital Management · Via GlobeNewswire · December 3, 2025
ORLANDO, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (NASDAQ: INV) (“Innventure”), an industrial growth conglomerate that commercializes breakthrough technologies, today announced its participation at the following investor conferences:
By Innventure, Inc. · Via GlobeNewswire · December 3, 2025
ISSAQUAH, Wash., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $23.64 billion for the retail month of November, the four weeks ended November 30, 2025, an increase of 8.1 percent from $21.87 billion last year.
By Costco Wholesale Corporation · Via GlobeNewswire · December 3, 2025
- FER X Tender Award for an RtB 79.5 MW Solar Project in Italy- First Withdrawal under the Project Finance for a 198 MW Solar Portfolio
By Ellomay Capital Ltd · Via GlobeNewswire · December 3, 2025
AUSTIN, Texas, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), the largest global provider of cloud- and carrier-neutral data center, colocation and interconnection solutions, announced today that Digital Euro Finco, LLC, a wholly owned indirect finance subsidiary of Digital Realty’s operating partnership, has given notice of its intention to redeem all of its outstanding 2.500% Guaranteed Notes due 2026, pursuant to its option under the indenture governing the 2.500% notes, dated as of January 16, 2019. The redemption date is December 18, 2025, and the applicable redemption price is equal to par, plus accrued and unpaid interest thereon to, but not including, the redemption date. As of the date hereof, there was €1,075,000,000 aggregate principal amount of the 2.500% notes outstanding. Deutsche Trustee Company Limited is the trustee and Deutsche Bank AG, London Branch is the paying agent for 2.500% notes.
By Digital Realty Trust, L.P. · Via GlobeNewswire · December 3, 2025
SAXONBURG, Pa., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced a major milestone in its next-generation 300mm silicon carbide (SiC) platform to address increasing thermal efficiency demands in AI datacenter infrastructure.
By Coherent Corp. · Via GlobeNewswire · December 3, 2025
REDWOOD CITY, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (the “Company” or “Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that on December 1, 2025 (the “Grant Date”), Pulmonx granted equity awards under its 2025 Inducement Plan (the “Inducement Plan”) for an aggregate of 1,625,000 shares of Pulmonx’s common stock to two individuals hired by Pulmonx in the fourth quarter of 2025, including Pulmonx’s Chief Financial Officer and Chief Operating Officer, Derrick Sung. The awards were approved by the Compensation Committee of the Company’s Board of Directors and were granted as an inducement material to the new employees entering into employment with Pulmonx, in accordance with Nasdaq Listing Rule 5635(c)(4). Each award is subject to the terms and conditions of the Inducement Plan and the grant agreements covering the awards.
By Pulmonx Corporation · Via GlobeNewswire · December 3, 2025
WALTHAM, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced the Company will host a virtual key opinion leader (KOL) event to discuss updated data from the ALLOHA™ Phase 1 trial being presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition and the future market opportunity for its heme program. The virtual event will take place on Monday, December 8, at 8:00 a.m. ET.
By TScan Therapeutics, Inc. · Via GlobeNewswire · December 3, 2025
WILMINGTON, N.C., Dec. 03, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced financial results for the third quarter of fiscal year 2026, ended October 31, 2025.
By nCino, Inc. · Via GlobeNewswire · December 3, 2025
ROCKVILLE, Md., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack A. Khattar, President and CEO of Supernus Pharmaceuticals, will present at the Bank of America Securities 2025 CNS Therapeutics Virtual Conference on Monday, December 8, 2025, at 3:20 p.m. ET.
By Supernus Pharmaceuticals, Inc. · Via GlobeNewswire · December 3, 2025
Technology executives Andy Yasutake and Diego Dugatkin bring deep AI product innovation and expertise to nCino's Board of Directors
By nCino, Inc. · Via GlobeNewswire · December 3, 2025
EL MONTE, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that it has entered into a definitive Share Purchase Agreement to acquire 100% of the outstanding equity of New Classic Home Furnishings, Inc.
By GigaCloud Technology · Via GlobeNewswire · December 3, 2025
BOSTON, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that on December 1, 2025, the Compensation Committee of Praxis’ Board of Directors granted restricted stock unit awards covering an aggregate of 3,594 shares of its common stock to six new non-executive employees under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The restricted stock unit awards were granted as inducements material to the employees’ entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4).
By Praxis Precision Medicines, Inc. · Via GlobeNewswire · December 3, 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on December 1, 2025, the Company granted inducement awards to purchase up to 15,500 shares of common stock to one new employee under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates.
By Syndax Pharmaceuticals, Inc. · Via GlobeNewswire · December 3, 2025
Company to host a conference call and webcast on Saturday, December 6, 2025, at 8:00 pm ET
By ORIC Pharmaceuticals · Via GlobeNewswire · December 3, 2025
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · December 3, 2025
- Zacks Small-Cap Research and Senior Analyst Tom Kerr, CFA, today initiated independent research coverage of Blue Gold Limited
By Blue Gold Limited · Via GlobeNewswire · December 3, 2025
Carina Davidson named interim CEO, Michael Hotra and Sydney Isaacs named Co-Presidents
By H/Advisors Abernathy · Via GlobeNewswire · December 3, 2025
AI-powered, non-custodial solution provides instant liquidity for artworks — a financial innovation long overdue in the art world
By CashArt · Via GlobeNewswire · December 3, 2025
Maranello (Italy), 3 December 2025 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) announces that it has signed a Euro 350 million unsecured committed revolving credit facility, intended for general corporate and working capital purposes (the “New RCF”).
By Ferrari N.V. · Via GlobeNewswire · December 3, 2025
Los Angeles, CA, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Warp announced today that it has been officially recognized as a certified SmartWay® Transport Partner carrier by the U.S. Environmental Protection Agency (EPA). This designation marks a significant milestone in the company’s commitment to delivering cleaner, more efficient, and cost-effective freight transportation.
By Warp · Via GlobeNewswire · December 3, 2025
MISSION, Kan., Dec. 03, 2025 (GLOBE NEWSWIRE) -- (Family Features) The holiday season is a time for creating meals and memories that last a lifetime, but it’s also one of the busiest times of the year. In the blur of commitments, crowded schedules and endless prep, the tension between a desire to create magical meals and wanting to actually enjoy them is real.
By Family Features · Via GlobeNewswire · December 3, 2025
PRESS RELEASE
By Theon International PLC · Via GlobeNewswire · December 3, 2025
The "Not famous but known" bagel shop, famous for introducing the “Grip, Rip and Dip" food craze, expands with 13 new locations to come across New England
By PopUp Bagels · Via GlobeNewswire · December 3, 2025
SAN FRANCISCO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Despite global economic uncertainty, entrepreneurship is on the rise. Small businesses are approaching 2026 with confidence - with 69% year-over-year increase in LinkedIn members adding ‘founder’ to their profile, and more than half of small business leaders are optimistic about the year ahead. The research points to three key growth engines powering small businesses:
By LinkedIn · Via GlobeNewswire · December 3, 2025
